Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 11225 - 11232 of 12008 results
Cleaning Water with Oil: Inexpensive and Energy-Efficient
December 11, 2012| Blog| Viewpoint
"Fly Delta" May Get Grounded by California Attorney General
December 10, 2012| Blog| Viewpoint
David Can Beat Goliath in the Trademark World… Just Ask Mixed Chicks!
December 7, 2012| Blog| Viewpoint
Gov. Patrick's Housing Initiative Deserves Praise
December 7, 2012| News
CA, MA and NY: Employment & Labor Laws 2013 Legislative Forecast
December 6, 2012| Blog| Viewpoint
Off Label Marketing - First Amendment Challenge Ruling
December 6, 2012| Blog| Viewpoint
How Do You or Don’t You State a Case for A Declaratory Judgment in a Trademark Dispute?
December 5, 2012| Blog| Viewpoint
The Tale of Two Banks: Final Settlement in Maine Bank Security Practices Case and a Failure of Bank Security Procedures in Florida
December 5, 2012| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|